Every year, US-based non-dilutive sources of funding award billions of dollars towards clinical stage research in the Life Sciences.
Funding is available for clinical stage funding across scientific fields including Infectious Diseases, Neurosciences, Cardiovascular, and many more. These funds come from multiple Institutes within the NIH, such as NIAID, NIAMS, NIDDK, from BARDA, and from the DOD.
In this webinar, we discuss the process for applying, guidelines, key success components and insight into increasing chances for award.
Purpose: To solicit research applications for milestone-driven projects focused on preclinical development of lead candidate countermeasures (therapeutics, vaccines and related technologies, or diagnostics) against select NIAID Emerging Infectious Diseases/Pathogens.
Application Due Date: October 3, 2016
Budget: Direct costs of up to $750,000 per year may be requested. Applicants may also request up to an additional $300,000 in the first year of the award for major equipment to ensure that research objectives can be met and biohazards can be contained, totaling $1,050,000 direct costs.
Total Award: ~4,000,000 over 5 years
To discuss this opportunity or to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!
Purpose: NSF’s SBIR and STTR programs provide non-dilutive funds for early-stage research and development (R&D) at small businesses. This R&D should be based on innovative, transformational technology with potential for substantial commercial and/or societal benefits. The programs invite proposals from small businesses across a broad range of science and engineering disciplines. For the STTR program, this must be in collaboration with researchers at universities, Federally-Funded Research and Development Centers, and other non-profit institutions.
Application Due Dates:
SBIR Phase I Proposal: June 16, 2016
STTR Phase I Proposal: June 20, 2016
Budget: $225,000 for a 6-12 month development/ feasibility project. You can then compete for a second grant of up to $750,000 over a 2 year period, with the aim of advancing the technology toward commercial deployment.
Biological Technologies (BT)
- BT3. Life Sciences Research Tools
- BT4. Bioinstrumentation
- BT7. Computational Biology and Bioinformatics
- BT8. Advanced Biomanufacturing- New Topic
- BT9. Advanced technologies for functional genomics in organismal systems – New Topic
- Tissue Engineering and Regenerative Medicine
Smart Health (SH) and Biomedical (BM) Technologies
- SH1. Business Models for User-Centered Healthcare
- SH2. Digital Health Information Infrastructure
- SH3. From Data to Decisions
- SH4. Interoperability of Health Record Systems, Medical Sensors, Devices and Robotics
- BM1. Pharmaceutical Manufacturing
- BM2. Materials for Biomedical Applications
- BM3. Biomedical Engineering
- BM4. Noninvasive Imaging of Brain Function
- BM5. Medical Imaging Technologies
- BM6. Diagnostic Assays and Platforms
- BM7. Drug Delivery
To discuss these opportunities or to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!